Is a Challenge to FDA’s “Route-of-Abuse” 3-Year Exclusivity Approach to Abuse-Deterrent Drug Products on the Horizon?

Is a Challenge to FDA’s “Route-of-Abuse” 3-Year Exclusivity Approach to Abuse-Deterrent Drug Products on the Horizon?

Submitted by admin on April 7, 2017 - 12:04am
Source: 
FDA Law Blog
News Tags: 
FDA
exclusivity
off-label
Egalet
Headline: 
Is a Challenge to FDA’s “Route-of-Abuse” 3-Year Exclusivity Approach to Abuse-Deterrent Drug Products on the Horizon?

Do Not Allow Advertisers to Use My Personal information